Rigel Pharmaceuticals, Inc. (RIGL)
USD 17.04
(3.34%)
USD 17.04
(3.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 116.88 Million | 120.24 Million | 149.23 Million | 108.62 Million | 59.28 Million | 44.5 Million |
| Cost of Revenue | 7.11 Million | 1.74 Million | 1.08 Million | 895 Thousand | 906 Thousand | 287 Thousand |
| Gross Profit | 109.77 Million | 118.49 Million | 148.15 Million | 107.72 Million | 58.38 Million | 44.22 Million |
| Operating Expenses | 130.26 Million | 172.72 Million | 157.12 Million | 136.69 Million | 127.47 Million | 116.9 Million |
| Selling, General and Administrative Expenses | 105.74 Million | 112.45 Million | 91.89 Million | 76.59 Million | 74.58 Million | 70 Million |
| Research and Development Expenses | 24.52 Million | 60.27 Million | 65.23 Million | 60.1 Million | 52.88 Million | 46.9 Million |
| Other Expenses | - | 1.32 Million | 3.52 Million | - | - | - |
| Cost and Expenses | 137.37 Million | 174.47 Million | 158.21 Million | 137.59 Million | 128.37 Million | 117.19 Million |
| Operating Income | -20.49 Million | -54.23 Million | -8.97 Million | -28.97 Million | -69.09 Million | -72.68 Million |
| Interest Expense | 6.87 Million | 3.7 Million | 4.86 Million | 1.35 Million | 335 Thousand | - |
| Income Tax Expense | - | 3.02 Million | 605 Thousand | 647 Thousand | -348 Thousand | 2.2 Million |
| Earnings before Tax | -25.09 Million | -58.57 Million | -17.3 Million | -29.74 Million | -66.89 Million | -70.48 Million |
| Net Income | -25.09 Million | -61.59 Million | -17.91 Million | -30.39 Million | -66.54 Million | -70.48 Million |
| Earnings Per Share Basic | -1.44 | -3.40 | -1.05 | -1.76 | -4.00 | -4.39 |
| Earnings Per Share Diluted | -1.44 | -3.40 | -1.05 | -1.76 | -4.00 | -4.39 |
| Weighted Average Shares Outstanding | 17.4 Million | 17.24 Million | 17.04 Million | 16.87 Million | 16.72 Million | 16.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.4 Million | 17.24 Million | 17.04 Million | 16.87 Million | 16.73 Million | 16.05 Million |
| Gross Margin | 0.94 | 0.99 | 0.99 | 0.99 | 0.98 | 0.99 |
| EBIT Margin | -0.15 | -0.45 | -0.06 | -0.26 | -1.12 | -1.63 |
| Profit Margin | -0.21 | -0.51 | -0.12 | -0.28 | -1.12 | -1.58 |
| EBITDA | -16.98 Million | -53.86 Million | -11.28 Million | -27.68 Million | -65.87 Million | -69.88 Million |
| Earnings Before Tax Margin | -0.18 | -0.45 | -0.06 | -0.27 | -1.17 | -1.63 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 36.84 Million | 29.53 Million | 35.79 Million | 116.88 Million | 28.13 Million | 26.88 Million |
| Cost of Revenue | 2.8 Million | 2.02 Million | 3.79 Million | 7.11 Million | 1.26 Million | 1.07 Million |
| Gross Profit | 34.03 Million | 27.5 Million | 32 Million | 109.77 Million | 26.86 Million | 25.81 Million |
| Operating Expenses | 33.58 Million | 34.47 Million | 30.03 Million | 130.26 Million | 31.33 Million | 31.07 Million |
| Selling, General and Administrative Expenses | 28.04 Million | 28.44 Million | 26.85 Million | - | 24.85 Million | 26.3 Million |
| Research and Development Expenses | 5.54 Million | 6.02 Million | 3.18 Million | - | 6.47 Million | 4.77 Million |
| Other Expenses | -5.53 Million | - | - | - | - | - |
| Cost and Expenses | 36.39 Million | 36.5 Million | 33.82 Million | 137.37 Million | 32.59 Million | 32.15 Million |
| Operating Income | 447 Thousand | -6.96 Million | 1.96 Million | -20.49 Million | -4.46 Million | -5.26 Million |
| Interest Expense | 2.02 Million | 1.87 Million | 1.9 Million | 6.87 Million | 1.89 Million | 1.86 Million |
| Income Tax Expense | - | 356.72 Thousand | 678 Thousand | 2.27 Million | 672 Thousand | 233 Thousand |
| Earnings before Tax | -1.03 Million | -8.24 Million | 737 Thousand | -25.09 Million | -5.69 Million | -6.6 Million |
| Net Income | -1.03 Million | -8.24 Million | 737 Thousand | -25.09 Million | -5.69 Million | -6.6 Million |
| Earnings Per Share Basic | -0.06 | -0.05 | 0.00 | - | -0.03 | -0.04 |
| Earnings Per Share Diluted | -0.06 | -0.05 | 0.00 | - | -0.03 | -0.04 |
| Weighted Average Shares Outstanding | 17.54 Million | 175.2 Million | 174.37 Million | 174.01 Million | 174.36 Million | 173.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.54 Million | 175.2 Million | 174.46 Million | 174.01 Million | 174.36 Million | 173.74 Million |
| Gross Margin | 0.92 | 0.93 | 0.89 | 0.94 | 0.95 | 0.96 |
| EBIT Margin | 0.03 | -0.22 | 0.08 | - | -0.12 | -0.18 |
| Profit Margin | -0.03 | -0.28 | 0.02 | -0.21 | -0.20 | -0.25 |
| EBITDA | 1.06 Million | -6.56 Million | 2.93 Million | - | -3.5 Million | -4.73 Million |
| Earnings Before Tax Margin | 0.01 | -0.24 | 0.05 | -0.18 | -0.16 | -0.20 |
5401
FATBW
BHVN
AXL
AER
LFCOF